Literature DB >> 15817677

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

Susann Fält1, Mats Merup, Gerard Tobin, Ulf Thunberg, Gösta Gahrton, Richard Rosenquist, Anders Wennborg.   

Abstract

The usage of the immunoglobulin (Ig) V(H)3-21 gene is associated with poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL) despite V(H) gene mutation status. Many V(H)3-21+ patients also display restricted heavy- and light-chain Ig gene rearrangements, implying a role of antigen selection in disease development. To explore the specific phenotypic/genotypic features among V(H)3-21+ B-CLLs, we compared gene expression patterns in 15 V(H)3-21+ and 24 non-V(H)3-21 patients (11 with unmutated and 13 with mutated V(H) genes) using Affymetrix microarray analysis (approximately 12,500 genes). A distinct expression profile was identified for V(H)3-21+ patients in contrast to the Ig-unmutated and -mutated groups. By applying different algorithms, the data enabled an efficient class discrimination of the V(H)3-21+ subset based on 27 or 57 genes. A set of genes was sorted out which, using different analytical methods, consistently gave a distinction between V(H)3-21+ and non-V(H)3-21 samples. Several of these genes are involved in regulation of DNA replication/cell-cycle control, transcription and protein kinase activity, which may render the V(H)3-21+ cells with a higher proliferative drive. However, no clear evidence of increased B-cell receptor signaling was found in the V(H)3-21+ group. Altogether, our identification of a specific V(H)3-21 profile may provide insights into the pathogenesis of the V(H)3-21+ subgroup.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817677     DOI: 10.1182/blood-2004-10-4073

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.

Authors:  Millaray Marincevic; Mahmoud Mansouri; Meena Kanduri; Anders Isaksson; Hanna Göransson; Karin Ekström Smedby; Jesper Jurlander; Gunnar Juliusson; Fred Davi; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

2.  Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2010-12       Impact factor: 9.941

3.  Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.

Authors:  Siang Tean Chin; Joshua Ignatius; Siti Suraiya; Gee Jun Tye; Maria E Sarmiento; Armando Acosta; Mohd Nor Norazmi; Theam Soon Lim
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

4.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

5.  Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

Authors:  Maria Gounari; Stavroula Ntoufa; Benedetta Apollonio; Nikos Papakonstantinou; Maurilio Ponzoni; Charles C Chu; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Kostas Stamatopoulos; Paolo Ghia
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

6.  Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.

Authors:  James S Blachly; Amy S Ruppert; Weiqiang Zhao; Susan Long; Joseph Flynn; Ian Flinn; Jeffrey Jones; Kami Maddocks; Leslie Andritsos; Emanuela M Ghia; Laura Z Rassenti; Thomas J Kipps; Albert de la Chapelle; John C Byrd
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-18       Impact factor: 11.205

7.  Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.

Authors:  Amit K Mittal; Nagendra K Chaturvedi; Karan J Rai; Christine E Gilling-Cutucache; Tara M Nordgren; Margaret Moragues; Runqing Lu; Rene Opavsky; Greg R Bociek; Dennis D Weisenburger; Javeed Iqbal; Shantaram S Joshi
Journal:  Mol Med       Date:  2014-07-15       Impact factor: 6.354

8.  Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Authors:  Meena Kanduri; Millaray Marincevic; Anna M Halldórsdóttir; Larry Mansouri; Katarina Junevik; Stavroula Ntoufa; Hanna Göransson Kultima; Anders Isaksson; Gunnar Juliusson; Per-Ola Andersson; Hans Ehrencrona; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Epigenetics       Date:  2012-11-15       Impact factor: 4.528

9.  IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.

Authors:  Ferran Nadeu; Romina Royo; Guillem Clot; Martí Duran-Ferrer; Alba Navarro; Silvia Martín; Junyan Lu; Thorsten Zenz; Tycho Baumann; Pedro Jares; Xose S Puente; José I Martín-Subero; Julio Delgado; Elías Campo
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

10.  Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail.

Authors:  Salim Essakali; Dennis Carney; David Westerman; Peter Gambell; John F Seymour; Alexander Dobrovic
Journal:  BMC Biotechnol       Date:  2008-01-29       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.